BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2727917)

  • 1. [Incidence, intensity and clinical manifestations of antral gastritis in duodenal ulcer in women and their relation to Campylobacter pylori].
    Orlovskiĭ VF; Medvedev VN; Krivokhatskaia IuA
    Ter Arkh; 1989; 61(2):33-5. PubMed ID: 2727917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of Campylobacter pylori in the clinical course of chronic antral gastritis and duodenal ulcer].
    Kalinin AV; Spesivtsev VN; Sedletskiĭ VA; Belogolovtsev VA
    Klin Med (Mosk); 1989 Oct; 67(10):64-6. PubMed ID: 2615309
    [No Abstract]   [Full Text] [Related]  

  • 3. [Campylobacter pylori in chronic gastritis].
    Maaroos KhI
    Ter Arkh; 1989; 61(2):35-7. PubMed ID: 2727918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Campylobacter pylori in patients with chronic gastritis and gastric and duodenal peptic ulcer].
    Kolarski V; Tsenova V; Shopova K; Vasileva E; Petrova D
    Vutr Boles; 1989; 28(2):58-62. PubMed ID: 2763525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Campylobacter pyloridis in peptic ulcer].
    Aruin LI; Smotrova IA; Il'chenko AA
    Arkh Patol; 1988; 50(2):13-8. PubMed ID: 3377694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Campylobacter pyloridis" and epigastric pain: endoscopic, histological, and bacteriological correlations.
    Lamouliatte H; Megraud F; de Mascarel A; Roux D; Quinton A
    Gastroenterol Clin Biol; 1987 Mar; 11(3):212-6. PubMed ID: 3582869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Campylobacter pyloric, chronic gastritis, gastric ulcer and duodenal ulcer].
    Ramírez-Ramos A; Recavarren-Arce S; León-Barúa R; Gilman R; Spira W; Watanabe-Yamamoto J; Garrido-Klinge G; Cok-García J; Zevallos-Coronado E; Rodríguez-Ulloa C
    Arq Gastroenterol; 1987; 24(1):10-5. PubMed ID: 3329902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy.
    Dooley CP; McKenna D; Humphreys H; Bourke S; Keane CT; Sweeney E; O'Morain C
    Am J Gastroenterol; 1988 Mar; 83(3):278-82. PubMed ID: 3344730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Has Campylobacter pylori infection any clinical relevance? Methodologic, epidemiologic and clinical studies].
    Döbrönte Z; Lakatos F; Brittig F; Löcsei Z; Bokor N; Stöckert A; Varga L
    Orv Hetil; 1989 Nov; 130(48):2563-8. PubMed ID: 2689946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sucralfate and cimetidine on duodenal ulcer-associated antral gastritis and Campylobacter pylori.
    Hui WM; Lam SK; Ho J; Ng I; Lau WY; Branicki FJ; Lai CL; Lok AS; Ng MM; Fok J
    Am J Med; 1989 Jun; 86(6A):60-5. PubMed ID: 2660558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Campylobacter pyloridis in the upper gastrointestinal tract: a Brazilian study.
    Coelho LG; Das SS; Karim QN; Walker MM; Queiroz DM; Mendes EN; Lima Júnior GF; de Oliveira CA; Baron JH; Castro Lde P
    Arq Gastroenterol; 1987; 24(1):5-9. PubMed ID: 3450271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of gastritis in patients with Helicobacter pylori-positive reflux esophagitis.
    Mihara T; Adachi K; Komazawa Y; Yoshida M; Araki A; Maruyama R; Furuta K; Ishihara S; Amano Y; Kinoshita Y
    J Gastroenterol Hepatol; 2005 May; 20(5):682-7. PubMed ID: 15853979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of Campylobacter pylori and gastritis in the stomach of patients with and without duodenal ulcer.
    Queiroz DM; Barbosa AJ; Mendes EN; Rocha GA; Cisalpino EO; Lima GF; Oliveira CA
    Am J Gastroenterol; 1988 Dec; 83(12):1368-70. PubMed ID: 3195542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Campylobacter pylori in duodenal and gastric mucosa--relationship to inflammation.
    Johnston BJ; Reed PI; Ali MH
    Scand J Gastroenterol Suppl; 1988; 142():69-75. PubMed ID: 3166535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of short-term lansoprazole therapy on Helicobacter pylori infection and antral gastritis in duodenal ulcer patients.
    Jhala NC; McFarland MM; Brightman SA; Morale B; Rubin W; Atkinson BF
    Am J Gastroenterol; 1995 Oct; 90(10):1824-8. PubMed ID: 7572902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-8 activity correlates with histological severity in Helicobacter pylori-associated antral gastritis.
    Ando T; Kusugami K; Ohsuga M; Shinoda M; Sakakibara M; Saito H; Fukatsu A; Ichiyama S; Ohta M
    Am J Gastroenterol; 1996 Jun; 91(6):1150-6. PubMed ID: 8651162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Campylobacter pylori in esophagitis, gastritis, and duodenal disease.
    Cheng EH; Bermanski P; Silversmith M; Valenstein P; Kawanishi H
    Arch Intern Med; 1989 Jun; 149(6):1373-5. PubMed ID: 2730254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphology and dynamics of the gastric mucosa in duodenal ulcer patients and their first-degree relatives.
    Tarpila S; Kekki M; Samloff IM; Sipponen P; Siurala M
    Hepatogastroenterology; 1983 Oct; 30(5):198-201. PubMed ID: 6642406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Campylobacter pylori and gastric mucosa: histological and bacteriological study and preliminary results of an epidemiological survey in the area of Nantes].
    Le Bodic MF; Barré P; Freland C; Cerbelaud P; Bruley Des Varannes S; Lavignolle A; Drugeon H; Le Bodic L; Galmiche JP
    Gastroenterol Clin Biol; 1987; 11(8-9):543-9. PubMed ID: 3653616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Occurrence of Campylobacter pylori in patients with gastritis and peptic ulcer].
    Carneiro Leão G; Magalhães Filho M; Galvão LP; Machado RC; Padovan IP; Jucá NT; Lira VM; Magalhães M
    Arq Gastroenterol; 1988; 25(1):23-8. PubMed ID: 3223826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.